Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Caplin Point Laboratories Ltd.
NSE: CAPLIPOINT
|
BSE: 524742
|
ISIN: INE475E01026
|
Industry: Pharmaceuticals
US FDA Observation
|
Strong Performer, Getting Expensive
2496.1000
-64.70
(
-2.53
%)
NSE
Aug 24, 2026
15:31 PM
66.37% Gain from 52W Low
Volume:
210.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Caplin Point Laboratories Ltd.
08 Aug 2024
US FDA Observation
2496.10
-2.53%
Caplin Point Laboratories
Buy:
Caplin Point Laboratories ...
by
ICICI Direct
Target: 1980
Target
ICICI Direct
Caplin Point Laboratories Ltd. is trading
above its 200 day SMA
of 2012.5
More from Caplin Point Laboratories Ltd.
Recommended
Market closes lower, led by losses in banking and finance stocks
Trendlyne Marketwatch |
24 Aug 2026, 04:04PM
Five Interesting Stocks Today - August 21, 2026
The Baseline |
21 Aug 2026
Caplin Point Laboratories maintains export momentum, expands ambitions to new markets
|
01 Jul 2022